Author:
Liu Lihua,Lim Mi Ae,Jung Seung-Nam,Oh Chan,Won Ho-Ryun,Jin Yan Li,Piao Yudan,Kim Hae Jong,Chang Jae Won,Koo Bon Seok
Funder
National Research Foundation of Korea
Ministry of Education, Science and Technology
Chungnam National University
Ministry of Health and Welfare
Korea Health Industry Development Institute
Subject
Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine
Reference67 articles.
1. Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation;Anderson;Immunity,2016
2. Nivolumab plus ipilimumab versus existing immunotherapies in patients with PD-L1-positive advanced non-small cell lung cancer: a systematic review and network meta-analysis;Ando;Cancers,2020
3. Expression of Tim-3 drives naïve Treg to an effector-like state with enhanced suppressive activity;Banerjee;BioRxiv,2020
4. Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts;Bhattacharyya;Cell Mol. Immunol.,2010
5. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination;Boutros;Nature reviews,2016
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献